Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2021 (text version)
Updated 6 November 2024
Applies to England
1. Gram-negative bacteraemias (E. coli, Klebsiella spp. and P. aeruginosa)
P. aeruginosa bacteraemia
October to December 2019 8 out of every 100,000 persons developed a P. aeruginosa bacteraemia.
October to December 2021 8 out of every 100,000 persons developed a P. aeruginosa bacteraemia.
Klebsiella spp. bacteraemia
October to December 2019 21 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.
October to December 2021 22 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.
E. coli bacteraemia
October to December 2019 75 out of every 100,000 persons developed an E. coli bacteraemia.
October to December 2021 65 out of every 100,000 persons developed an E. coli bacteraemia.
2. S. aureus (MRSA and MSSA) bacteraemia and C. difficile infections
MRSA bacteraemia
October to December 2019 1.6 out of every 100,000 persons developed an MRSA bacteraemia.
October to December 2021 1.2 out of every 100,000 persons developed an MRSA bacteraemia.
MSSA bacteraemia
October to December 2019 22 out of every 100,000 persons developed an MSSA bacteraemia.
October to December 2021 22 out of every 100,000 persons developed an MSSA bacteraemia.
C. difficile infection
October to December 2019 24 out of every 100,000 persons developed a C. difficile infection.
October to December 2021 25 out of every 100,000 persons developed a C. difficile infection.